NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination

Buyer Contact Info

Buyer Name: NHS England North East And Yorkshire

Buyer Address: City Office Park 3 Leeds City Office Park Holbeck, Leeds, UKE, LS11 5BD, United Kingdom

Contact Email: necsu.psrprocurement@nhs.net

Status
complete

Procedure
limited

Value
n/a

Published
29 Aug 2025, 15:21

Deadline
n/a

Contract Start
n/a

Contract End
n/a

Category
services

CPV
85140000 - Miscellaneous health services

Region
n/a

Awarded To
Lincolnshire Community Health Services NHS Trust, City Health Care Partnership CIC, Leeds Community Healthcare NHS Trust, Locala Community Partnerships CIC, Spectrum Community Health CIC, Solutions 4 Health

Official Source
Open Find a Tender

Description

NHS England - North East and Yorkshire (the Relevant Authority) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards. Following the government's acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement: • a routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK • a routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK The Relevant Authority is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population. The JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines. Individuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme. Funding of £10.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional £8.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year. As these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years. Providers should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025. Eligible providers must: • Hold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process. • Pass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire. To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Locations/Lots: Yorkshire & Humber: • Lot 1 - North Lincolnshire and North East Lincolnshire • Lot 2 - Hull • Lot 3 - East Riding • Lot 4 - Leeds • Lot 5 - Bradford • Lot 6 - Kirklees • Lot 7 - Wakefield • Lot 8 - Barnsley • Lot 9 - Doncaster North East and North Cumbria: • Lot 10 - Newcastle Upon Tyne

Linked Documents

No linked documents found for this notice.

Opportunity Context

Lots

Lot Title: Lot 1 - North Lincolnshire and North East Lincolnshire

Lot Description: NHS England - North East and Yorkshire (the Relevant Authority) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards. Following the government's acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement: • a routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK • a routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK The Relevant Authority is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population. Eligibility The JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines. Individuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme. Activity/funding Funding of £10.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional £8.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year. As these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years. Delivery date Providers should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025. Provider Eligibility Criteria: Eligible providers must: • Hold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process. • Pass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire. Contract Term: To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Location/Lot: Yorkshire & Humber: • Lot 1 - North Lincolnshire and North East Lincolnshire - service to commence by 01 September with an expiry 31 March 2029 - with option to extend for 2-years (1+1).

Lot 1 Status: cancelled

Lot 1 Has Options: Yes

Lot 1 Options: The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Lot 1 - North Lincolnshire and North East Lincolnshire - service to commence by 01 September with an expiry 31 March 2029 - with option to extend for 2-years (1+1).

Lot 1 Award Criterion (quality): Patient Choice

Lot 1 Award Criterion (cost): Patient Choice

Lot Title: Lot 2 - Hull

Lot Description: NHS England - North East and Yorkshire (the Relevant Authority) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards. Following the government's acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement: • a routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK • a routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK The Relevant Authority is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population. Eligibility The JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines. Individuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme. Activity/funding Funding of £10.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional £8.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year. As these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years. Delivery date Providers should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025. Provider Eligibility Criteria: Eligible providers must: • Hold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process. • Pass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire. Contract Term: To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Location/Lot: Yorkshire & Humber: • Lot 2 - Hull - service to commence by 01 September with an expiry 01 April 2026 with option to extend for 6-years (4+2).

Lot 2 Status: cancelled

Lot 2 Has Options: Yes

Lot 2 Options: The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: • Lot 2 - Hull - service to commence by 01 September with an expiry 01 April 2026 with option to extend for 6-years (4+2).

Lot 2 Award Criterion (quality): Patient Choice

Lot 2 Award Criterion (cost): Patient Choice

Lot Title: Lot 3 - East Riding

Lot Description: NHS England - North East and Yorkshire (the Relevant Authority) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards. Following the government's acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement: • a routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK • a routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK The Relevant Authority is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population. Eligibility The JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines. Individuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme. Activity/funding Funding of £10.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional £8.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year. As these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years. Delivery date Providers should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025. Provider Eligibility Criteria: Eligible providers must: • Hold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process. • Pass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire. Contract Term: To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Location/Lot: Yorkshire & Humber: Lot 3 - East Riding - service to commence by 01 September with an expiry 31 March 2026.

Lot 3 Status: cancelled

Lot 3 Has Options: Yes

Lot 3 Options: The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Lot 3 - East Riding - service to commence by 01 September with an expiry 31 March 2026.

Lot 3 Award Criterion (quality): Patient Choice

Lot 3 Award Criterion (cost): Patient Choice

Lot Title: Lot 4 - Leeds

Lot Description: NHS England - North East and Yorkshire (the Relevant Authority) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards. Following the government's acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement: • a routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK • a routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK The Relevant Authority is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population. Eligibility The JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines. Individuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme. Activity/funding Funding of £10.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional £8.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year. As these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years. Delivery date Providers should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025. Provider Eligibility Criteria: Eligible providers must: • Hold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process. • Pass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire. Contract Term: To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Location/Lot: Yorkshire & Humber: • Lot 4 - Leeds - service to commence by 01 September with an expiry 31 March 2030 with option to extend by 4-years.

Lot 4 Status: cancelled

Lot 4 Has Options: Yes

Lot 4 Options: The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Lot 4 - Leeds - service to commence by 01 September with an expiry 31 March 2030 with option to extend by 4-years.

Lot 4 Award Criterion (quality): Patient Choice

Lot 4 Award Criterion (cost): Patient Choice

Lot Title: Lot 5 - Bradford

Lot Description: NHS England - North East and Yorkshire (the Relevant Authority) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards. Following the government's acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement: • a routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK • a routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK The Relevant Authority is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population. Eligibility The JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines. Individuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme. Activity/funding Funding of £10.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional £8.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year. As these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years. Delivery date Providers should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025. Provider Eligibility Criteria: Eligible providers must: • Hold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process. • Pass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire. Contract Term: To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Location/Lot: Yorkshire & Humber: • Lot 5 - Bradford - service to commence by 01 September with an expiry 31 March 2033.

Lot 5 Status: cancelled

Lot 5 Has Options: Yes

Lot 5 Options: The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Lot 5 - Bradford - service to commence by 01 September with an expiry 31 March 2033.

Lot 5 Award Criterion (quality): Patient Choice

Lot 5 Award Criterion (cost): Patient Choice

Lot Title: Lot 6 - Kirklees

Lot Description: NHS England - North East and Yorkshire (the Relevant Authority) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards. Following the government's acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement: • a routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK • a routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK The Relevant Authority is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population. Eligibility The JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines. Individuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme. Activity/funding Funding of £10.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional £8.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year. As these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years. Delivery date Providers should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025. Provider Eligibility Criteria: Eligible providers must: • Hold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process. • Pass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire. Contract Term: To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Location/Lot: Yorkshire & Humber: • Lot 6 - Kirklees - service to commence by 01 September with an expiry 31 March 2032.

Lot 6 Status: cancelled

Lot 6 Has Options: Yes

Lot 6 Options: The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Lot 6 - Kirklees - service to commence by 01 September with an expiry 31 March 2032.

Lot 6 Award Criterion (quality): Patient Choice

Lot 6 Award Criterion (cost): Patient Choice

Lot Title: Lot 7 - Wakefield

Lot Description: NHS England - North East and Yorkshire (the Relevant Authority) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards. Following the government's acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement: • a routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK • a routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK The Relevant Authority is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population. Eligibility The JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines. Individuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme. Activity/funding Funding of £10.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional £8.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year. As these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years. Delivery date Providers should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025. Provider Eligibility Criteria: Eligible providers must: • Hold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process. • Pass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire. Contract Term: To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Location/Lot: Yorkshire & Humber: • Lot 7 - Wakefield - service to commence by 01 September with an expiry 30 September 2031.

Lot 7 Status: cancelled

Lot 7 Has Options: Yes

Lot 7 Options: The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Lot 7 - Wakefield - service to commence by 01 September with an expiry 30 September 2031.

Lot 7 Award Criterion (quality): Patient Choice

Lot 7 Award Criterion (cost): Patient Choice

Lot Title: Lot 8 - Barnsley

Lot Description: NHS England - North East and Yorkshire (the Relevant Authority) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards. Following the government's acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement: • a routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK • a routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK The Relevant Authority is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population. Eligibility The JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines. Individuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme. Activity/funding Funding of £10.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional £8.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year. As these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years. Delivery date Providers should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025. Provider Eligibility Criteria: Eligible providers must: • Hold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process. • Pass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire. Contract Term: To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Location/Lot: Yorkshire & Humber: • Lot 8 - Barnsley - service to commence by 01 September with an expiry 30 June 2028.

Lot 8 Status: cancelled

Lot 8 Has Options: Yes

Lot 8 Options: The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Lot 8 - Barnsley - service to commence by 01 September with an expiry 30 June 2028.

Lot 8 Award Criterion (quality): Patient Choice

Lot 8 Award Criterion (cost): Patient Choice

Lot Title: Lot 9 - Doncaster

Lot Description: NHS England - North East and Yorkshire (the Relevant Authority) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards. Following the government's acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement: • a routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK • a routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK The Relevant Authority is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population. Eligibility The JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines. Individuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme. Activity/funding Funding of £10.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional £8.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year. As these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years. Delivery date Providers should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025. Provider Eligibility Criteria: Eligible providers must: • Hold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process. • Pass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire. Contract Term: To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Location/Lot: Yorkshire & Humber: • Lot 9 - Doncaster - service to commence by 01 September with an expiry 30 September 2027.

Lot 9 Status: cancelled

Lot 9 Has Options: Yes

Lot 9 Options: The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Lot 9 - Doncaster - service to commence by 01 September with an expiry 30 September 2027.

Lot 9 Award Criterion (quality): Patient Choice

Lot 9 Award Criterion (cost): Patient Choice

Lot Title: Lot 10 - Newcastle Upon Tyne

Lot Description: NHS England - North East and Yorkshire (the Relevant Authority) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards. Following the government's acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement: • a routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK • a routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK The Relevant Authority is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population. Eligibility The JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines. Individuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme. Activity/funding Funding of £10.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional £8.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year. As these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years. Delivery date Providers should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025. Provider Eligibility Criteria: Eligible providers must: • Hold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process. • Pass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire. Contract Term: To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Location/Lot: North East and North Cumbria: • Lot 10 - Newcastle Upon Tyne - service to commence by 01 September expiry 30 September 2030.

Lot 10 Status: cancelled

Lot 10 Has Options: Yes

Lot 10 Options: The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Lot 10 - Newcastle Upon Tyne - service to commence by 01 September expiry 30 September 2030.

Lot 10 Award Criterion (quality): Patient Choice

Lot 10 Award Criterion (cost): Patient Choice

Contracts

Contract Title: NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination

Awards

Award Title: NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination

Raw Notice JSON

Expand raw payload

{
  "awards": [
    {
      "id": "052590-2025-Lot 1 - North Lincolnshire and North East Lincolnshire-1",
      "status": "active",
      "suppliers": [
        {
          "id": "GB-NHS-RY5",
          "name": "Lincolnshire Community Health Services NHS Trust"
        }
      ],
      "title": "NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination"
    },
    {
      "id": "052590-2025-Lot 2 - Hull-2",
      "status": "active",
      "suppliers": [
        {
          "id": "GB-COH-06273905",
          "name": "City Health Care Partnership CIC"
        }
      ],
      "title": "NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination"
    },
    {
      "id": "052590-2025-Lot 3 - East Riding-3",
      "status": "active",
      "suppliers": [
        {
          "id": "GB-COH-06273905",
          "name": "City Health Care Partnership CIC"
        }
      ],
      "title": "NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination"
    },
    {
      "id": "052590-2025-Lot 4 - Leeds-4",
      "status": "active",
      "suppliers": [
        {
          "id": "GB-NHS-RY6",
          "name": "Leeds Community Healthcare NHS Trust"
        }
      ],
      "title": "NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination"
    },
    {
      "id": "052590-2025-Lot 5 - Bradford-5",
      "status": "active",
      "suppliers": [
        {
          "id": "GB-COH-07584906",
          "name": "Locala Community Partnerships CIC"
        }
      ],
      "title": "NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination"
    },
    {
      "id": "052590-2025-Lot 6 - Kirklees-6",
      "status": "active",
      "suppliers": [
        {
          "id": "GB-COH-07584906",
          "name": "Locala Community Partnerships CIC"
        }
      ],
      "title": "NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination"
    },
    {
      "id": "052590-2025-Lot 7 - Wakefield-7",
      "status": "active",
      "suppliers": [
        {
          "id": "GB-COH-07300133",
          "name": "Spectrum Community Health CIC"
        }
      ],
      "title": "NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination"
    },
    {
      "id": "052590-2025-Lot 8 - Barnsley-8",
      "status": "active",
      "suppliers": [
        {
          "id": "GB-COH-07300133",
          "name": "Spectrum Community Health CIC"
        }
      ],
      "title": "NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination"
    },
    {
      "id": "052590-2025-Lot 9 - Doncaster-9",
      "status": "active",
      "suppliers": [
        {
          "id": "GB-COH-06475161",
          "name": "Solutions 4 Health"
        }
      ],
      "title": "NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination"
    },
    {
      "id": "052590-2025-Lot 10 - Newcastle Upon Tyne-10",
      "status": "active",
      "suppliers": [
        {
          "id": "GB-COH-06475161",
          "name": "Solutions 4 Health"
        }
      ],
      "title": "NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination"
    }
  ],
  "bids": {
    "statistics": [
      {
        "id": "5",
        "measure": "bids",
        "value": 1
      },
      {
        "id": "8",
        "measure": "bids",
        "value": 1
      },
      {
        "id": "11",
        "measure": "bids",
        "value": 1
      },
      {
        "id": "14",
        "measure": "bids",
        "value": 1
      },
      {
        "id": "17",
        "measure": "bids",
        "value": 1
      },
      {
        "id": "20",
        "measure": "bids",
        "value": 1
      },
      {
        "id": "23",
        "measure": "bids",
        "value": 1
      },
      {
        "id": "26",
        "measure": "bids",
        "value": 1
      },
      {
        "id": "29",
        "measure": "bids",
        "value": 1
      },
      {
        "id": "32",
        "measure": "bids",
        "value": 1
      },
      {
        "currency": "GBP",
        "id": "3",
        "measure": "lowestValidBidValue",
        "value": 0.01
      },
      {
        "currency": "GBP",
        "id": "6",
        "measure": "lowestValidBidValue",
        "value": 0.01
      },
      {
        "currency": "GBP",
        "id": "9",
        "measure": "lowestValidBidValue",
        "value": 0.01
      },
      {
        "currency": "GBP",
        "id": "12",
        "measure": "lowestValidBidValue",
        "value": 0.01
      },
      {
        "currency": "GBP",
        "id": "15",
        "measure": "lowestValidBidValue",
        "value": 0.01
      },
      {
        "currency": "GBP",
        "id": "18",
        "measure": "lowestValidBidValue",
        "value": 0.01
      },
      {
        "currency": "GBP",
        "id": "21",
        "measure": "lowestValidBidValue",
        "value": 0.01
      },
      {
        "currency": "GBP",
        "id": "24",
        "measure": "lowestValidBidValue",
        "value": 0.01
      },
      {
        "currency": "GBP",
        "id": "27",
        "measure": "lowestValidBidValue",
        "value": 0.01
      },
      {
        "currency": "GBP",
        "id": "30",
        "measure": "lowestValidBidValue",
        "value": 0.01
      },
      {
        "currency": "GBP",
        "id": "4",
        "measure": "highestValidBidValue",
        "value": 18.06
      },
      {
        "currency": "GBP",
        "id": "7",
        "measure": "highestValidBidValue",
        "value": 18.06
      },
      {
        "currency": "GBP",
        "id": "10",
        "measure": "highestValidBidValue",
        "value": 18.06
      },
      {
        "currency": "GBP",
        "id": "13",
        "measure": "highestValidBidValue",
        "value": 18.06
      },
      {
        "currency": "GBP",
        "id": "16",
        "measure": "highestValidBidValue",
        "value": 18.06
      },
      {
        "currency": "GBP",
        "id": "19",
        "measure": "highestValidBidValue",
        "value": 18.06
      },
      {
        "currency": "GBP",
        "id": "22",
        "measure": "highestValidBidValue",
        "value": 18.06
      },
      {
        "currency": "GBP",
        "id": "25",
        "measure": "highestValidBidValue",
        "value": 18.06
      },
      {
        "currency": "GBP",
        "id": "28",
        "measure": "highestValidBidValue",
        "value": 18.06
      },
      {
        "currency": "GBP",
        "id": "31",
        "measure": "highestValidBidValue",
        "value": 18.06
      },
      {
        "currency": "GBP",
        "id": "1",
        "measure": "lowestValidBidValue",
        "value": 0.01
      },
      {
        "currency": "GBP",
        "id": "2",
        "measure": "highestValidBidValue",
        "value": 18.06
      }
    ]
  },
  "buyer": {
    "id": "GB-NHS-(Q72)",
    "name": "NHS England North East And Yorkshire"
  },
  "contracts": [
    {
      "awardID": "052590-2025-Lot 1 - North Lincolnshire and North East Lincolnshire-1",
      "dateSigned": "2025-08-20T00:00:00+01:00",
      "id": "052590-2025-Lot 1 - North Lincolnshire and North East Lincolnshire-1",
      "status": "active",
      "title": "NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination"
    },
    {
      "awardID": "052590-2025-Lot 2 - Hull-2",
      "dateSigned": "2025-08-20T00:00:00+01:00",
      "id": "052590-2025-Lot 2 - Hull-2",
      "status": "active",
      "title": "NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination"
    },
    {
      "awardID": "052590-2025-Lot 3 - East Riding-3",
      "dateSigned": "2025-08-20T00:00:00+01:00",
      "id": "052590-2025-Lot 3 - East Riding-3",
      "status": "active",
      "title": "NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination"
    },
    {
      "awardID": "052590-2025-Lot 4 - Leeds-4",
      "dateSigned": "2025-08-20T00:00:00+01:00",
      "id": "052590-2025-Lot 4 - Leeds-4",
      "status": "active",
      "title": "NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination"
    },
    {
      "awardID": "052590-2025-Lot 5 - Bradford-5",
      "dateSigned": "2025-08-20T00:00:00+01:00",
      "id": "052590-2025-Lot 5 - Bradford-5",
      "status": "active",
      "title": "NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination"
    },
    {
      "awardID": "052590-2025-Lot 6 - Kirklees-6",
      "dateSigned": "2025-08-20T00:00:00+01:00",
      "id": "052590-2025-Lot 6 - Kirklees-6",
      "status": "active",
      "title": "NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination"
    },
    {
      "awardID": "052590-2025-Lot 7 - Wakefield-7",
      "dateSigned": "2025-08-20T00:00:00+01:00",
      "id": "052590-2025-Lot 7 - Wakefield-7",
      "status": "active",
      "title": "NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination"
    },
    {
      "awardID": "052590-2025-Lot 8 - Barnsley-8",
      "dateSigned": "2025-08-20T00:00:00+01:00",
      "id": "052590-2025-Lot 8 - Barnsley-8",
      "status": "active",
      "title": "NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination"
    },
    {
      "awardID": "052590-2025-Lot 9 - Doncaster-9",
      "dateSigned": "2025-08-20T00:00:00+01:00",
      "id": "052590-2025-Lot 9 - Doncaster-9",
      "status": "active",
      "title": "NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination"
    },
    {
      "awardID": "052590-2025-Lot 10 - Newcastle Upon Tyne-10",
      "dateSigned": "2025-08-20T00:00:00+01:00",
      "id": "052590-2025-Lot 10 - Newcastle Upon Tyne-10",
      "status": "active",
      "title": "NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination"
    }
  ],
  "date": "2025-08-29T16:21:16+01:00",
  "description": "The Relevant Authority intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) Regulations 2023.\nAll new services - All existing providers.\nFor the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards.\nDetails of individual making decisions:\nDeputy Head of Public Health, Yorkshire and the Humber, NHS England (North East and Yorkshire).\nSenior Commissioning Manager - North East and North Cumbria, NHS England (North East and Yorkshire).\nScreening and Immunisation Place Lead North Lincolnshire and North East Lincolnshire Y\u0026H Public Health Programmes Team NHS England (North East \u0026 Yorkshire).\nFinance Manager - Direct Commissioning (HJ \u0026 PH), NHS England Regional Team - North East \u0026 Yorkshire.\nNorth East and North Cumbria Public Health Commissioning Management Group.\nThere were no conflicts of Interest.",
  "id": "052590-2025",
  "initiationType": "tender",
  "language": "en",
  "ocid": "ocds-h6vhtk-0590ce",
  "parties": [
    {
      "address": {
        "countryName": "United Kingdom",
        "locality": "Leeds",
        "postalCode": "LS11 5BD",
        "region": "UKE",
        "streetAddress": "City Office Park 3 Leeds City Office Park Holbeck"
      },
      "contactPoint": {
        "email": "necsu.psrprocurement@nhs.net"
      },
      "details": {
        "classifications": [
          {
            "description": "Body governed by public law",
            "id": "BODY_PUBLIC",
            "scheme": "TED_CA_TYPE"
          },
          {
            "description": "Health",
            "id": "07",
            "scheme": "COFOG"
          }
        ],
        "url": "https://www.england.nhs.uk/north-east-yorkshire/"
      },
      "id": "GB-NHS-(Q72)",
      "identifier": {
        "id": "(Q72)",
        "legalName": "NHS England North East And Yorkshire",
        "scheme": "GB-NHS"
      },
      "name": "NHS England North East And Yorkshire",
      "roles": [
        "buyer"
      ]
    },
    {
      "address": {
        "countryName": "United Kingdom",
        "locality": "Lincoln",
        "postalCode": "LN5 7JH",
        "region": "UKE13",
        "streetAddress": "Beech House,  Witham Park,  Waterside South"
      },
      "details": {
        "scale": "large",
        "url": "https://lincolnshirecommunityhealthservices.nhs.uk/contact-us"
      },
      "id": "GB-NHS-RY5",
      "identifier": {
        "id": "RY5",
        "legalName": "Lincolnshire Community Health Services NHS Trust",
        "scheme": "GB-NHS"
      },
      "name": "Lincolnshire Community Health Services NHS Trust",
      "roles": [
        "supplier"
      ]
    },
    {
      "address": {
        "countryName": "United Kingdom",
        "locality": "Hull",
        "postalCode": "HU3 4AE",
        "region": "UKE11",
        "streetAddress": "5 Beacon Way"
      },
      "details": {
        "scale": "large",
        "url": "https://www.chcpcic.org.uk/pages/head-office"
      },
      "id": "GB-COH-06273905",
      "identifier": {
        "id": "06273905",
        "legalName": "City Health Care Partnership CIC",
        "scheme": "GB-COH"
      },
      "name": "City Health Care Partnership CIC",
      "roles": [
        "supplier"
      ]
    },
    {
      "address": {
        "countryName": "United Kingdom",
        "locality": "Leeds",
        "postalCode": "LS11 0DL",
        "region": "UKE42",
        "streetAddress": "White Rose Office Park,  Building 3 Millshaw Park Lane"
      },
      "details": {
        "scale": "large",
        "url": "https://leedscommunityhealthcare.nhs.uk/contact-us/"
      },
      "id": "GB-NHS-RY6",
      "identifier": {
        "id": "RY6",
        "legalName": "Leeds Community Healthcare NHS Trust",
        "scheme": "GB-NHS"
      },
      "name": "Leeds Community Healthcare NHS Trust",
      "roles": [
        "supplier"
      ]
    },
    {
      "address": {
        "countryName": "United Kingdom",
        "locality": "Liversedge",
        "postalCode": "WF15 6LP",
        "region": "UKE4",
        "streetAddress": "Eddercliffe Health Centre,  Bradford Road,"
      },
      "details": {
        "scale": "large",
        "url": "https://www.locala.org.uk/"
      },
      "id": "GB-COH-07584906",
      "identifier": {
        "id": "07584906",
        "legalName": "Locala Community Partnerships CIC",
        "scheme": "GB-COH"
      },
      "name": "Locala Community Partnerships CIC",
      "roles": [
        "supplier"
      ]
    },
    {
      "address": {
        "countryName": "United Kingdom",
        "locality": "Wakefield",
        "postalCode": "WF1 5RH",
        "region": "UKE45",
        "streetAddress": "1 Navigation Walk,  Hebble Wharf,"
      },
      "details": {
        "scale": "large",
        "url": "https://spectrum-cic.org.uk/"
      },
      "id": "GB-COH-07300133",
      "identifier": {
        "id": "07300133",
        "legalName": "Spectrum Community Health CIC",
        "scheme": "GB-COH"
      },
      "name": "Spectrum Community Health CIC",
      "roles": [
        "supplier"
      ]
    },
    {
      "address": {
        "countryName": "United Kingdom",
        "locality": "Reading",
        "postalCode": "RG1 8EQ",
        "region": "UKJ1",
        "streetAddress": "Head Office  Unit 1 Thames Court Richfield Avenue"
      },
      "details": {
        "scale": "large",
        "url": "https://www.solutions4health.co.uk/about-us/"
      },
      "id": "GB-COH-06475161",
      "identifier": {
        "id": "06475161",
        "legalName": "Solutions 4 Health",
        "scheme": "GB-COH"
      },
      "name": "Solutions 4 Health",
      "roles": [
        "supplier"
      ]
    },
    {
      "address": {
        "countryName": "United Kingdom",
        "locality": "Leeds",
        "postalCode": "LS11 5BD",
        "streetAddress": "City Office Park 3 Leeds City Office Park Holbeck"
      },
      "contactPoint": {
        "email": "necsu.psrprocurement@nhs.net"
      },
      "details": {
        "url": "https://www.england.nhs.uk/north-east-yorkshire/"
      },
      "id": "GB-FTS-159290",
      "identifier": {
        "legalName": "NHS England North East And Yorkshire"
      },
      "name": "NHS England North East And Yorkshire",
      "roles": [
        "reviewBody"
      ]
    }
  ],
  "tag": [
    "award",
    "contract"
  ],
  "tender": {
    "classification": {
      "description": "Miscellaneous health services",
      "id": "85140000",
      "scheme": "CPV"
    },
    "coveredBy": [
      "GPA"
    ],
    "description": "NHS England - North East and Yorkshire (the Relevant Authority) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards.\nFollowing the government\u0027s acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement: \n\u2022\ta routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK \n\u2022\ta routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK \nThe Relevant Authority is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population. \nThe JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines. \nIndividuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme. \nFunding of \u00a310.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional \u00a38.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year. \nAs these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years. \nProviders should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025. \nEligible providers must: \n\u2022\tHold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process. \n\u2022\tPass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire. \nTo commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority:\nLocations/Lots:\nYorkshire \u0026 Humber:\n\u2022\tLot 1 - North Lincolnshire and North East Lincolnshire \n\u2022\tLot 2 - Hull \n\u2022\tLot 3 - East Riding \n\u2022\tLot 4 - Leeds \n\u2022\tLot 5 - Bradford \n\u2022\tLot 6 - Kirklees \n\u2022\tLot 7 - Wakefield \n\u2022\tLot 8 - Barnsley \n\u2022\tLot 9 - Doncaster \nNorth East and North Cumbria:\n\u2022\tLot 10 - Newcastle Upon Tyne",
    "id": "NHSE1088",
    "items": [
      {
        "additionalClassifications": [
          {
            "description": "Miscellaneous health services",
            "id": "85140000",
            "scheme": "CPV"
          }
        ],
        "deliveryAddresses": [
          {
            "region": "UKE13"
          }
        ],
        "deliveryLocation": {
          "description": "Lot 1 - North Lincolnshire and North East Lincolnshire"
        },
        "id": "1",
        "relatedLot": "1"
      },
      {
        "additionalClassifications": [
          {
            "description": "Miscellaneous health services",
            "id": "85140000",
            "scheme": "CPV"
          }
        ],
        "deliveryAddresses": [
          {
            "region": "UKE11"
          }
        ],
        "deliveryLocation": {
          "description": "Lot 2 - Hull"
        },
        "id": "2",
        "relatedLot": "2"
      },
      {
        "additionalClassifications": [
          {
            "description": "Miscellaneous health services",
            "id": "85140000",
            "scheme": "CPV"
          }
        ],
        "deliveryAddresses": [
          {
            "region": "UKE12"
          }
        ],
        "deliveryLocation": {
          "description": "Lot 3 - East Riding"
        },
        "id": "3",
        "relatedLot": "3"
      },
      {
        "additionalClassifications": [
          {
            "description": "Miscellaneous health services",
            "id": "85140000",
            "scheme": "CPV"
          }
        ],
        "deliveryAddresses": [
          {
            "region": "UKE42"
          }
        ],
        "deliveryLocation": {
          "description": "Lot 4 - Leeds"
        },
        "id": "4",
        "relatedLot": "4"
      },
      {
        "additionalClassifications": [
          {
            "description": "Miscellaneous health services",
            "id": "85140000",
            "scheme": "CPV"
          }
        ],
        "deliveryAddresses": [
          {
            "region": "UKE41"
          }
        ],
        "deliveryLocation": {
          "description": "Lot 5 - Bradford"
        },
        "id": "5",
        "relatedLot": "5"
      },
      {
        "additionalClassifications": [
          {
            "description": "Miscellaneous health services",
            "id": "85140000",
            "scheme": "CPV"
          }
        ],
        "deliveryAddresses": [
          {
            "region": "UKE4"
          }
        ],
        "deliveryLocation": {
          "description": "Lot 6 - Kirklees"
        },
        "id": "6",
        "relatedLot": "6"
      },
      {
        "additionalClassifications": [
          {
            "description": "Miscellaneous health services",
            "id": "85140000",
            "scheme": "CPV"
          }
        ],
        "deliveryAddresses": [
          {
            "region": "UKE45"
          }
        ],
        "deliveryLocation": {
          "description": "Lot 7 - Wakefield"
        },
        "id": "7",
        "relatedLot": "7"
      },
      {
        "additionalClassifications": [
          {
            "description": "Miscellaneous health services",
            "id": "85140000",
            "scheme": "CPV"
          }
        ],
        "deliveryAddresses": [
          {
            "region": "UKE31"
          }
        ],
        "deliveryLocation": {
          "description": "Lot 8 - Barnsley"
        },
        "id": "8",
        "relatedLot": "8"
      },
      {
        "additionalClassifications": [
          {
            "description": "Miscellaneous health services",
            "id": "85140000",
            "scheme": "CPV"
          }
        ],
        "deliveryAddresses": [
          {
            "region": "UKE31"
          }
        ],
        "deliveryLocation": {
          "description": "Lot 9 - Doncaster"
        },
        "id": "9",
        "relatedLot": "9"
      },
      {
        "additionalClassifications": [
          {
            "description": "Miscellaneous health services",
            "id": "85140000",
            "scheme": "CPV"
          }
        ],
        "deliveryAddresses": [
          {
            "region": "UKC22"
          }
        ],
        "deliveryLocation": {
          "description": "Lot 10 - Newcastle Upon Tyne"
        },
        "id": "10",
        "relatedLot": "10"
      }
    ],
    "legalBasis": {
      "id": "32014L0024",
      "scheme": "CELEX"
    },
    "lots": [
      {
        "awardCriteria": {
          "criteria": [
            {
              "description": "100",
              "name": "Patient Choice",
              "type": "quality"
            },
            {
              "description": "100",
              "name": "Patient Choice",
              "type": "cost"
            }
          ]
        },
        "description": "NHS England - North East and Yorkshire (the Relevant Authority) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards.\nFollowing the government\u0027s acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement: \n\u2022\ta routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK \n\u2022\ta routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK \nThe Relevant Authority is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population. \nEligibility \nThe JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines. \nIndividuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme. \nActivity/funding \nFunding of \u00a310.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional \u00a38.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year. \nAs these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years. \nDelivery date \nProviders should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025. \nProvider Eligibility Criteria: \nEligible providers must: \n\u2022\tHold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process. \n\u2022\tPass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire. \nContract Term: \nTo commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority:\nLocation/Lot:\nYorkshire \u0026 Humber:\n\u2022\tLot 1 - North Lincolnshire and North East Lincolnshire - service to commence by 01 September with an expiry 31 March 2029 - with option to extend for 2-years (1+1).",
        "hasOptions": true,
        "id": "1",
        "options": {
          "description": "The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Lot 1 - North Lincolnshire and North East Lincolnshire - service to commence by 01 September with an expiry 31 March 2029 - with option to extend for 2-years (1+1)."
        },
        "status": "cancelled",
        "title": "Lot 1 - North Lincolnshire and North East Lincolnshire"
      },
      {
        "awardCriteria": {
          "criteria": [
            {
              "description": "100",
              "name": "Patient Choice",
              "type": "quality"
            },
            {
              "description": "100",
              "name": "Patient Choice",
              "type": "cost"
            }
          ]
        },
        "description": "NHS England - North East and Yorkshire (the Relevant Authority) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards.\nFollowing the government\u0027s acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement: \n\u2022\ta routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK \n\u2022\ta routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK \nThe Relevant Authority is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population. \nEligibility \nThe JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines. \nIndividuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme. \nActivity/funding \nFunding of \u00a310.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional \u00a38.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year. \nAs these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years. \nDelivery date \nProviders should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025. \nProvider Eligibility Criteria: \nEligible providers must: \n\u2022\tHold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process. \n\u2022\tPass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire. \nContract Term: \nTo commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority:\nLocation/Lot:\nYorkshire \u0026 Humber:\n\u2022\tLot 2 - Hull - service to commence by 01 September with an expiry 01 April 2026 with option to extend for 6-years (4+2).",
        "hasOptions": true,
        "id": "2",
        "options": {
          "description": "The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: \u2022\tLot 2 - Hull - service to commence by 01 September with an expiry 01 April 2026 with option to extend for 6-years (4+2)."
        },
        "status": "cancelled",
        "title": "Lot 2 - Hull"
      },
      {
        "awardCriteria": {
          "criteria": [
            {
              "description": "100",
              "name": "Patient Choice",
              "type": "quality"
            },
            {
              "description": "100",
              "name": "Patient Choice",
              "type": "cost"
            }
          ]
        },
        "description": "NHS England - North East and Yorkshire (the Relevant Authority) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards.\nFollowing the government\u0027s acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement: \n\u2022\ta routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK \n\u2022\ta routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK \nThe Relevant Authority is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population. \nEligibility \nThe JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines. \nIndividuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme. \nActivity/funding \nFunding of \u00a310.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional \u00a38.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year. \nAs these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years. \nDelivery date \nProviders should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025. \nProvider Eligibility Criteria: \nEligible providers must: \n\u2022\tHold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process. \n\u2022\tPass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire. \nContract Term: \nTo commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority:\nLocation/Lot:\nYorkshire \u0026 Humber:\nLot 3 - East Riding - service to commence by 01 September with an expiry 31 March 2026.",
        "hasOptions": true,
        "id": "3",
        "options": {
          "description": "The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Lot 3 - East Riding - service to commence by 01 September with an expiry 31 March 2026."
        },
        "status": "cancelled",
        "title": "Lot 3 - East Riding"
      },
      {
        "awardCriteria": {
          "criteria": [
            {
              "description": "100",
              "name": "Patient Choice",
              "type": "quality"
            },
            {
              "description": "100",
              "name": "Patient Choice",
              "type": "cost"
            }
          ]
        },
        "description": "NHS England - North East and Yorkshire (the Relevant Authority) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards.\nFollowing the government\u0027s acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement: \n\u2022\ta routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK \n\u2022\ta routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK \nThe Relevant Authority is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population. \nEligibility \nThe JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines. \nIndividuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme. \nActivity/funding \nFunding of \u00a310.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional \u00a38.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year. \nAs these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years. \nDelivery date \nProviders should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025. \nProvider Eligibility Criteria: \nEligible providers must: \n\u2022\tHold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process. \n\u2022\tPass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire. \nContract Term: \nTo commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority:\nLocation/Lot:\nYorkshire \u0026 Humber:\n\u2022\tLot 4 - Leeds - service to commence by 01 September with an expiry 31 March 2030 with option to extend by 4-years.",
        "hasOptions": true,
        "id": "4",
        "options": {
          "description": "The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Lot 4 - Leeds - service to commence by 01 September with an expiry 31 March 2030 with option to extend by 4-years."
        },
        "status": "cancelled",
        "title": "Lot 4 - Leeds"
      },
      {
        "awardCriteria": {
          "criteria": [
            {
              "description": "100",
              "name": "Patient Choice",
              "type": "quality"
            },
            {
              "description": "100",
              "name": "Patient Choice",
              "type": "cost"
            }
          ]
        },
        "description": "NHS England - North East and Yorkshire (the Relevant Authority) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards.\nFollowing the government\u0027s acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement: \n\u2022\ta routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK \n\u2022\ta routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK \nThe Relevant Authority is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population. \nEligibility \nThe JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines. \nIndividuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme. \nActivity/funding \nFunding of \u00a310.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional \u00a38.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year. \nAs these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years. \nDelivery date \nProviders should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025. \nProvider Eligibility Criteria: \nEligible providers must: \n\u2022\tHold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process. \n\u2022\tPass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire. \nContract Term: \nTo commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority:\nLocation/Lot:\nYorkshire \u0026 Humber:\n\u2022\tLot 5 - Bradford - service to commence by 01 September with an expiry 31 March 2033.",
        "hasOptions": true,
        "id": "5",
        "options": {
          "description": "The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Lot 5 - Bradford - service to commence by 01 September with an expiry 31 March 2033."
        },
        "status": "cancelled",
        "title": "Lot 5 - Bradford"
      },
      {
        "awardCriteria": {
          "criteria": [
            {
              "description": "100",
              "name": "Patient Choice",
              "type": "quality"
            },
            {
              "description": "100",
              "name": "Patient Choice",
              "type": "cost"
            }
          ]
        },
        "description": "NHS England - North East and Yorkshire (the Relevant Authority) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards.\nFollowing the government\u0027s acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement: \n\u2022\ta routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK \n\u2022\ta routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK \nThe Relevant Authority is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population. \nEligibility \nThe JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines. \nIndividuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme. \nActivity/funding \nFunding of \u00a310.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional \u00a38.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year. \nAs these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years. \nDelivery date \nProviders should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025. \nProvider Eligibility Criteria: \nEligible providers must: \n\u2022\tHold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process. \n\u2022\tPass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire. \nContract Term: \nTo commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority:\nLocation/Lot:\nYorkshire \u0026 Humber:\n\u2022\tLot 6 - Kirklees - service to commence by 01 September with an expiry 31 March 2032.",
        "hasOptions": true,
        "id": "6",
        "options": {
          "description": "The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Lot 6 - Kirklees - service to commence by 01 September with an expiry 31 March 2032."
        },
        "status": "cancelled",
        "title": "Lot 6 - Kirklees"
      },
      {
        "awardCriteria": {
          "criteria": [
            {
              "description": "100",
              "name": "Patient Choice",
              "type": "quality"
            },
            {
              "description": "100",
              "name": "Patient Choice",
              "type": "cost"
            }
          ]
        },
        "description": "NHS England - North East and Yorkshire (the Relevant Authority) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards.\nFollowing the government\u0027s acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement: \n\u2022\ta routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK \n\u2022\ta routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK \nThe Relevant Authority is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population. \nEligibility \nThe JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines. \nIndividuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme. \nActivity/funding \nFunding of \u00a310.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional \u00a38.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year. \nAs these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years. \nDelivery date \nProviders should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025. \nProvider Eligibility Criteria: \nEligible providers must: \n\u2022\tHold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process. \n\u2022\tPass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire. \nContract Term: \nTo commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority:\nLocation/Lot:\nYorkshire \u0026 Humber:\n\u2022\tLot 7 - Wakefield - service to commence by 01 September with an expiry 30 September 2031.",
        "hasOptions": true,
        "id": "7",
        "options": {
          "description": "The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: \nLot 7 - Wakefield - service to commence by 01 September with an expiry 30 September 2031."
        },
        "status": "cancelled",
        "title": "Lot 7 - Wakefield"
      },
      {
        "awardCriteria": {
          "criteria": [
            {
              "description": "100",
              "name": "Patient Choice",
              "type": "quality"
            },
            {
              "description": "100",
              "name": "Patient Choice",
              "type": "cost"
            }
          ]
        },
        "description": "NHS England - North East and Yorkshire (the Relevant Authority) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards.\nFollowing the government\u0027s acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement: \n\u2022\ta routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK \n\u2022\ta routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK \nThe Relevant Authority is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population. \nEligibility \nThe JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines. \nIndividuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme. \nActivity/funding \nFunding of \u00a310.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional \u00a38.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year. \nAs these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years. \nDelivery date \nProviders should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025. \nProvider Eligibility Criteria: \nEligible providers must: \n\u2022\tHold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process. \n\u2022\tPass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire. \nContract Term: \nTo commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority:\nLocation/Lot:\nYorkshire \u0026 Humber:\n\u2022\tLot 8 - Barnsley - service to commence by 01 September with an expiry 30 June 2028.",
        "hasOptions": true,
        "id": "8",
        "options": {
          "description": "The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: \nLot 8 - Barnsley - service to commence by 01 September with an expiry 30 June 2028."
        },
        "status": "cancelled",
        "title": "Lot 8 - Barnsley"
      },
      {
        "awardCriteria": {
          "criteria": [
            {
              "description": "100",
              "name": "Patient Choice",
              "type": "quality"
            },
            {
              "description": "100",
              "name": "Patient Choice",
              "type": "cost"
            }
          ]
        },
        "description": "NHS England - North East and Yorkshire (the Relevant Authority) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards.\nFollowing the government\u0027s acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement: \n\u2022\ta routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK \n\u2022\ta routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK \nThe Relevant Authority is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population. \nEligibility \nThe JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines. \nIndividuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme. \nActivity/funding \nFunding of \u00a310.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional \u00a38.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year. \nAs these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years. \nDelivery date \nProviders should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025. \nProvider Eligibility Criteria: \nEligible providers must: \n\u2022\tHold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process. \n\u2022\tPass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire. \nContract Term: \nTo commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority:\nLocation/Lot:\nYorkshire \u0026 Humber:\n\u2022\tLot 9 - Doncaster - service to commence by 01 September with an expiry 30 September 2027.",
        "hasOptions": true,
        "id": "9",
        "options": {
          "description": "The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: \nLot 9 - Doncaster - service to commence by 01 September with an expiry 30 September 2027."
        },
        "status": "cancelled",
        "title": "Lot 9 - Doncaster"
      },
      {
        "awardCriteria": {
          "criteria": [
            {
              "description": "100",
              "name": "Patient Choice",
              "type": "quality"
            },
            {
              "description": "100",
              "name": "Patient Choice",
              "type": "cost"
            }
          ]
        },
        "description": "NHS England - North East and Yorkshire (the Relevant Authority) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards.\nFollowing the government\u0027s acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement: \n\u2022\ta routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK \n\u2022\ta routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK \nThe Relevant Authority is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population. \nEligibility \nThe JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines. \nIndividuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme. \nActivity/funding \nFunding of \u00a310.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional \u00a38.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year. \nAs these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years. \nDelivery date \nProviders should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025. \nProvider Eligibility Criteria: \nEligible providers must: \n\u2022\tHold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process. \n\u2022\tPass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire. \nContract Term: \nTo commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority:\nLocation/Lot:\nNorth East and North Cumbria:\n\u2022\tLot 10 - Newcastle Upon Tyne - service to commence by 01 September expiry 30 September 2030.",
        "hasOptions": true,
        "id": "10",
        "options": {
          "description": "The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: \nLot 10 - Newcastle Upon Tyne - service to commence by 01 September expiry 30 September 2030."
        },
        "status": "cancelled",
        "title": "Lot 10 - Newcastle Upon Tyne"
      }
    ],
    "mainProcurementCategory": "services",
    "procurementMethod": "limited",
    "procurementMethodDetails": "Award procedure without prior publication of a call for competition",
    "procurementMethodRationale": "The Relevant Authority intends to award this contract under the Direct Award Process B under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award.\nThere were no Conflicts of Interest.",
    "procurementMethodRationaleClassifications": [
      {
        "description": "The procurement falls outside the scope of application of the directive",
        "id": "D_OUTSIDE_SCOPE",
        "scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL"
      }
    ],
    "status": "complete",
    "title": "NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination"
  }
}